VCEL News and Press, Vericel Corporation

2024-06-27 14:03:15 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The medical field is a non-negotiable aspect of society. Advanced healthcare is required to combat existing diseases and protect ourselves from new ones. Constant innovation in the medical fiel...

A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 2.7% to $127.255 on volume of 88,797,787 shares Ascent Solar Technologies Inc (ASTI) rose 9.6% to $0.1183 on volume of 88,651,038 shares Crown Electrokinetics Corp. (CRKN) fell 19.0% to $0.040499 on volu...

CAMBRIDGE, Mass., June 11, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, and Joe Mara, CFO, will participate in a fireside chat at the Truist ...

2024-05-26 12:20:00 ET Summary Conestoga Capital Advisors LLC is a boutique, independent investment advisory firm specializing in the management of Micro, Small, SMid and Mid Cap Growth equities. Conestoga Capital Advisors utilizes a fundamental, bottom-up research process and employs...

CAMBRIDGE, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO and Joe Mara, CFO will participate in a fireside chat at the Leerink Pa...

2024-05-08 14:36:10 ET Vericel Corporation (VCEL) Q1 2024 Earnings Conference Call May 08, 2024 08:30 AM ET Company Participants Eric Burns - Vice President of Finance & Investor Relations Nick Colangelo - Chief Executive Officer Joe Mara - Chief Financial Of...

2024-05-08 07:58:55 ET More on Vericel Vericel Corporation 2023 Q4 - Results - Earnings Call Presentation Vericel Corporation (VCEL) Q4 2023 Earnings Call Transcript Vericel GAAP EPS of $0.26 beats by $0.09, revenue of $65M beats by $1.05M Seeking Alphaȁ...

Total Revenue Increased 25% to $51.3 Million Record First Quarter MACI Revenue of $40.2 Million and Burn Care Revenue Growth of 63% Adjusted EBITDA Growth of 325% Full-Year 2024 Revenue Guidance Raised to $238-$242 Million Conference Call Today at 8:30am Eastern ...

2024-05-07 11:43:45 ET More on Vericel Vericel Corporation 2023 Q4 - Results - Earnings Call Presentation Vericel Corporation (VCEL) Q4 2023 Earnings Call Transcript Vericel GAAP EPS of $0.26 beats by $0.09, revenue of $65M beats by $1.05M Seeking Alphaȁ...

CAMBRIDGE, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that it will report its first-quarter 2024 financial results on Wednesday, May 8, 2024. Vericel’s man...